U.S. law firm Goodwin Procter has hired private investment funds specialists Phil Culhane (L) and Elyn Xing as partners in Hong Kong. Culhane was running his own practice, Culhane & Associates, while Xing joins from Debevoise & Plimpton.

The duo join Goodwin Procter in Hong Kong a few months after the firm hired private equity expert Edwin Chan in June from Paul, Weiss, Rifkind, Wharton & Garrison.

Culhane has more than 30 years of experience, nearly 25 of which were spent with Simpson Thacher & Bartlett. He represents Asia-based alternative asset managers, from start-ups to multi-strategy firms.

Meanwhile, Xing, who also had a stint at STB, counsels on debt, energy, growth capital and emerging markets funds.

With the hires of Culhane and Xing, Goodwin Procter’s Hong Kong office now has 12 partners.


To contact the editorial team, please email

Related Articles

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.

HK: Goodwin adds debt finance expert from White & Case

by Nimitt Dixit |

U.S. law firm Goodwin Procter has made its first Hong Kong partner hire in 2023 with the addition of debt finance attorney Stephen Howard from White & Case, where he was a local partner.

Goodwin, MoFo, Slaughters guide $478 mln bio-pharma acquisition

by Nimitt Dixit |

U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.